A Phase II Study of Neo-Adjuvant Gemcitabine, Cisplatin and Bevacizumab in Stage IIIA (N2) Non-Squamous Cell Non-Small Cell Lung Cancer
Clinical trial NCT00924209 · TERMINATED
Trial details
- NCT number
- NCT00924209
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-01
- Primary completion
- 2011-09-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.